PB2021: PHASE 2 STUDY OF ORAL DECITABINE/CEDAZURIDINE IN COMBINATION WITH MAGROLIMAB FOR PREVIOUSLY UNTREATED SUBJECTS WITH INTERMEDIATE TO VERY HIGH-RISK MYELODYSPLASTIC SYNDROMES (MDS)

Detalles Bibliográficos
Autores principales: Zeidan, Amer M., Mosher, Karen, Souza, Sonia, Mirakhur, Beloo, Keer, Harold, Taylor, Jason
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Lippincott Williams & Wilkins 2023
Materias:
Publication Only
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC10429874/
http://dx.doi.org/10.1097/01.HS9.0000974892.81919.d4

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC10429874/
http://dx.doi.org/10.1097/01.HS9.0000974892.81919.d4

Ejemplares similares